Oncolytic viruses as anticancer vaccines
Oncolytic virotherapy has shown impressive results in preclinical studies and first promising therapeutic outcomes in clinical trials as well. Since viruses are known for a long time as excellent vaccination agents, oncolytic viruses are now designed as novel anticancer agents combining the aspect o...
Main Authors: | Norman eWoller, Engin eGürlevik, Cristina-Ileana eUreche, Anja eSchumacher, Florian eKühnel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00188/full |
Similar Items
-
Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies
by: Donald Bastin, et al.
Published: (2016-08-01) -
Editorial: Oncolytic Viruses—Genetically Engineering the Future of Cancer Therapy
by: Benjamin Gesundheit, et al.
Published: (2017-11-01) -
The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy
by: Jessica A. Minott, et al.
Published: (2022-09-01) -
Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
by: Fang Huang, et al.
Published: (2022-07-01) -
Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)